Cargando…

Mithramycin delivery systems to develop effective therapies in sarcomas

BACKGROUND: Sarcomas comprise a group of aggressive malignancies with very little treatment options beyond standard chemotherapy. Reposition of approved drugs represents an attractive approach to identify effective therapeutic compounds. One example is mithramycin (MTM), a natural antibiotic which h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Estupiñán, Óscar, Niza, Enrique, Bravo, Iván, Rey, Verónica, Tornín, Juan, Gallego, Borja, Clemente-Casares, Pilar, Moris, Francisco, Ocaña, Alberto, Blanco-Lorenzo, Verónica, Rodríguez-Santamaría, Mar, Vallina-Álvarez, Aitana, González, M. Victoria, Rodríguez, Aida, Hermida-Merino, Daniel, Alonso-Moreno, Carlos, Rodríguez, René
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419920/ https://www.ncbi.nlm.nih.gov/pubmed/34488783 http://dx.doi.org/10.1186/s12951-021-01008-x

Ejemplares similares

Nano-Encapsulation of Mithramycin in Transfersomes and Polymeric Micelles for the Treatment of Sarcomas
por: Estupiñán, Óscar, et al.
Publicado: (2021)

Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models
por: Gallego, Borja, et al.
Publicado: (2022)

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
por: Tornin, Juan, et al.
Publicado: (2016)

Proof of concept for the use of trained sniffer dogs to detect osteosarcoma
por: Ortal, Agustín, et al.
Publicado: (2022)

Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations
por: Martinez-Cruzado, Lucia, et al.
Publicado: (2016)

Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas
por: Menéndez, Sofía T., et al.
Publicado: (2021)

Mithramycin Treatment of Hypercalcaemia and Renal Failure in a Patient with Paratesticular Embryonic Sarcoma
por: Parsons, V., et al.
Publicado: (1971)

Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
por: Murillo, Dzohara, et al.
Publicado: (2023)

Genome-Wide Modulation of Gene Transcription in Ovarian Carcinoma Cells by a New Mithramycin Analogue
por: Vizcaíno, Carolina, et al.
Publicado: (2014)

New Chondrosarcoma Cell Lines with Preserved Stem Cell Properties to Study the Genomic Drift During In Vitro/In Vivo Growth
por: Rey, Veronica, et al.
Publicado: (2019)

Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity
por: Scott, Daniel, et al.
Publicado: (2011)

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models()
por: Martinez-Cruzado, Lucia, et al.
Publicado: (2017)

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
por: Federico, Aniello, et al.
Publicado: (2020)

SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications
por: Menendez, Sofia T., et al.
Publicado: (2020)

Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
por: Malek, Anastasia, et al.
Publicado: (2012)

A trial of mithramycin in the treatment of advanced malignant disease.
por: Sewell, I. A., et al.
Publicado: (1966)

Mithramycin interacts with core histones and modulates epigenetic modifications
por: Banerjee, Amrita, et al.
Publicado: (2013)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor
por: Chasse, Maggie H, et al.
Publicado: (2020)

The chromomycin CmmA acetyltransferase: a membrane‐bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin
por: García, Beatriz, et al.
Publicado: (2011)

A clinical trial of mithramycin in the treatment of advanced malignant disease.
por: Baum, M.
Publicado: (1968)

FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway()
por: Tornin, Juan, et al.
Publicado: (2017)

Global gene expression profiling data analysis reveals key gene families and biological processes inhibited by Mithramycin in sarcoma cell lines
por: Kulkarni, Kirti K., et al.
Publicado: (2014)

Mithramycin selectively attenuates DNA-damage-induced neuronal cell death
por: Makarevich, Oleg, et al.
Publicado: (2020)

The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions
por: Granda-Díaz, Rocío, et al.
Publicado: (2019)

Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma
por: Tornin, Juan, et al.
Publicado: (2019)

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042)
por: Fernández-Guizán, Azahara, et al.
Publicado: (2015)

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
por: Han, Dan, et al.
Publicado: (2019)

Letter: Renal function and electrolyte disturbances in normocalcaemic and hypercalcaemic patients treated with mithramycin.
por: Fillastre, J. P., et al.
Publicado: (1974)

Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells
por: Quarni, Waise, et al.
Publicado: (2019)

Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences
por: Barceló, Francisca, et al.
Publicado: (2007)

Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes
por: Liacini, Abdelhamid, et al.
Publicado: (2005)

Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia
por: Capretto, Lorenzo, et al.
Publicado: (2012)

Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1
por: Hou, Caixia, et al.
Publicado: (2016)

Mithramycin A Alleviates Osteoarthritic Cartilage Destruction by Inhibiting HIF-2α Expression
por: Choi, Moon-Chang, et al.
Publicado: (2018)

Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycin
por: Zabala, Daniel, et al.
Publicado: (2020)

Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection
por: Stagnoli, Soledad, et al.
Publicado: (2023)

Correlation of Micro-Computed Tomography Assessment of Valvular Mineralisation with Histopathological and Immunohistochemical Features of Calcific Aortic Valve Disease
por: Solache-Berrocal, Guillermo, et al.
Publicado: (2019)

Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder
por: Banerjee, Amrita, et al.
Publicado: (2014)

Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer
por: Choi, Eun-Sun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s8710k271dbhc0btfd7ksgphr7